Nitasha Sarswat to Retrospective Studies
This is a "connection" page, showing publications Nitasha Sarswat has written about Retrospective Studies.
Connection Strength
0.528
-
Incremental prognostic value of cardiac magnetic resonance beyond biomarker staging in transthyretin cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2026 Sep 01; 27(9):1603-1612.
Score: 0.021
-
Alternative Measures of Body Composition and Outcomes Following Heart Transplant. Clin Transplant. 2026 Feb; 40(2):e70448.
Score: 0.020
-
Association between listing hemodynamics and heart transplantation waitlist outcomes: An analysis of the Scientific Registry of Transplant Recipients. J Heart Lung Transplant. 2026 03; 45(3):350-362.
Score: 0.020
-
Disparities in diagnosis and outcomes in American patients with transthyretin cardiac amyloidosis. Int J Cardiovasc Imaging. 2025 Aug; 41(8):1487-1496.
Score: 0.020
-
Early and Late Outcomes of Ambulatory Counter Pulsation Devices as a Bridge to Heart Transplantation. Cardiology. 2025; 150(4):381-388.
Score: 0.019
-
Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype. Curr Probl Cardiol. 2024 Sep; 49(9):102729.
Score: 0.018
-
Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study. Eur Heart J Cardiovasc Imaging. 2024 05 31; 25(6):754-761.
Score: 0.018
-
Prevalence of valvular heart disease in cardiac amyloidosis and impact on survival. Curr Probl Cardiol. 2024 Apr; 49(4):102417.
Score: 0.018
-
Impact of prophylactic donor heart tricuspid valve annuloplasty on outcomes in heart transplantation. J Cardiothorac Surg. 2023 Oct 12; 18(1):288.
Score: 0.017
-
Preservation of Circumferential and Radial Left Ventricular Function as a Mitigating Mechanism for Impaired Longitudinal Strain in Early Cardiac Amyloidosis. J Am Soc Echocardiogr. 2023 12; 36(12):1290-1301.
Score: 0.017
-
Non-invasive diagnosis of transthyretin cardiac amyloidosis utilizing typical late gadolinium enhancement pattern on cardiac magnetic resonance and light chains. Eur Heart J Cardiovasc Imaging. 2023 05 31; 24(6):829-837.
Score: 0.017
-
Status One and Status Two Exception Use in the Updated Heart Allocation System. J Card Fail. 2023 06; 29(6):963-967.
Score: 0.017
-
The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices. Artif Organs. 2023 Mar; 47(3):574-581.
Score: 0.016
-
99m Technetium-pyrophosphate bone scan: A potential biomarker for the burden of transthyretin amyloidosis in skeletal muscle: A preliminary study. Muscle Nerve. 2023 Feb; 67(2):111-116.
Score: 0.016
-
Clinical outcomes of grafted vs. percutaneous axillary intra-aortic balloon pump support as a bridge to transplantation: a propensity score-matched analysis. Heart Vessels. 2022 Dec; 37(12):1995-2001.
Score: 0.016
-
Comparing short-term/long-term outcomes of heart transplants that occur inside and outside of normal working hours. ESC Heart Fail. 2022 08; 9(4):2484-2490.
Score: 0.016
-
Prevalence of Right Atrial Impairment and Association with Outcomes in Cardiac Amyloidosis. J Am Soc Echocardiogr. 2022 08; 35(8):829-835.e1.
Score: 0.016
-
Significant vascular complications in percutaneous axillary intra-aortic balloon pump. Ann Vasc Surg. 2022 Jul; 83:42-52.
Score: 0.015
-
Proximal ascending aorta size is associated with the incidence of de novo aortic insufficiency with left ventricular assist device. Heart Vessels. 2022 Apr; 37(4):647-653.
Score: 0.015
-
Aortic Pulsatility Index: A Novel Hemodynamic Variable for Evaluation of Decompensated Heart Failure. J Card Fail. 2021 10; 27(10):1045-1052.
Score: 0.015
-
Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure. Clin Cardiol. 2021 May; 44(5):636-645.
Score: 0.015
-
Outcomes of Ambulatory Axillary Intraaortic Balloon Pump as a Bridge to Heart Transplantation. Ann Thorac Surg. 2021 04; 111(4):1264-1270.
Score: 0.014
-
Short-Term Efficacy and Safety of Tolvaptan in Patients with Left Ventricular Assist Devices. ASAIO J. 2020 03; 66(3):253-257.
Score: 0.014
-
Combined Left Ventricular Assist Device and Coronary Artery Bypass Grafting Surgery: Should We Bypass the Bypass? ASAIO J. 2020 01; 66(1):32-37.
Score: 0.013
-
Surgical device exchange provides improved clinical outcomes compared to medical therapy in treating continuous-flow left ventricular assist device thrombosis. Artif Organs. 2020 Apr; 44(4):367-374.
Score: 0.013
-
A subcostal approach is favorable compared to sternotomy for left ventricular assist device exchange field of research: artificial heart (clinical). J Artif Organs. 2019 Sep; 22(3):181-187.
Score: 0.013
-
Home Inotropes in Patients Supported with Left Ventricular Assist Devices. ASAIO J. 2019 01; 65(1):e7-e11.
Score: 0.013
-
A histopathologic schema to quantify the burden of cardiac amyloidosis: Relationship with survival and echocardiographic parameters. Echocardiography. 2019 02; 36(2):285-291.
Score: 0.013
-
Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device. Circ Heart Fail. 2018 10; 11(10):e005082.
Score: 0.012
-
Impact of Residual Valve Disease on Survival After Implantation of Left Ventricular Assist Devices. Ann Thorac Surg. 2018 12; 106(6):1789-1796.
Score: 0.012
-
Echocardiographic Predictors of Hemodynamics in Patients Supported With Left Ventricular Assist Devices. J Card Fail. 2018 Sep; 24(9):561-567.
Score: 0.012
-
Increased Risk of Bleeding in Left Ventricular Assist Device Patients Treated with Enoxaparin as Bridge to Therapeutic International Normalized Ratio. ASAIO J. 2018 Mar/Apr; 64(2):140-146.
Score: 0.012
-
Long-Acting Octreotide Reduces the Recurrence of Gastrointestinal Bleeding in Patients With a Continuous-Flow Left Ventricular Assist Device. J Card Fail. 2018 Apr; 24(4):249-254.
Score: 0.012
-
Consequences of Retained Defibrillator and Pacemaker Leads After Heart Transplantation-An Underrecognized Problem. J Card Fail. 2018 02; 24(2):101-108.
Score: 0.012